Laurent Meijer

This inventor holds 23 USPTO granted patents and 5 published patent applications and 17 EPO patents. Top assignees: Centre National De La Recherche Scientifique, Université De Rennes 1, Université Paris Descartes. Active years: 2001-2025.

USPTO Granted Patents = 23 (Patent Applications = 5)

% Patents Active = 47.8

EPO Patents = 17 (Patent Applications = 23)

Average Co-Inventor Count = 3.9

ph-index = 5

Forward Citations = 100(Granted Patents)

Company Filing History:

12 out of 5,383

Centre National De La Recherche Scientifique

patents

3 out of 113

Université De Rennes 1

patents

3 out of 132

Université Paris Descartes

patents

4. 2 out of 2

Perha Pharmaceuticals

patents

5. 1 out of 4

Centre Hospitalier Universitaire De Brest

patents

6. 1 out of 8,816

Commissariat a L'energie Atomique Et Aux Energies Alternatives

patents

7. 1 out of 1

Institute of Experimental Botany, Academy of Science of the Czech Republic

National Institute of Health and Medical Research

The University of Chicago

patents

12. 1 out of 5,630

The University of Texas System

Université De Bretagne Occidentale

patents

15. 1 out of 63

Université De Poitiers

patents

16. 1 out of 1

Universitè{grave Over ( )} De Poitiers

patent

17. 1 out of 215

University Claude Bernard - Lyon 1

University of Pierre and Marie Curie (Paris 6)

patent

20. 1 out of 1

University of Rennes 1

patent

21. 7 out of 834,411

Other

patents

where one patent can have more than one assignee

Years Active: 2001-2025

Loading Chart...

23 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12398129 - Imidazolone derivatives as inhibitors of protein kinases in particular DYRK1A, CLK1 and/or CLK4 (2025-08-26),

2. 11472807 - Purine derivatives for use as medicament and for use in treating neurodegenerative or neuro-inflammatory disorders (2022-10-18),

3. 10561661 - Purine derivative compounds for medical use (2020-02-18),

4. 8999955 - Tetrahydrocyclopenta[c]acridine derivatives as kinase inhibitors and biological (2015-04-07),

5. 8829203 - 3',6-substituted indirubins and their biological applications (2014-09-09),

6. 8691982 - [object Object] (2014-04-08),

7. 8563588 - Imidazolone derivatives, method for the preparation thereof and biological applications (2013-10-22),

8. 8552053 - 7-substituted indirubin-3'oximes and their applications (2013-10-08),

9. 8492420 - Use of purine derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells (2013-07-23),

10. 8450342 - Perharidines as CDK inhibitors (2013-05-28),

11. 8431583 - Use of purine derivatives for the manufacture of a medicament (2013-04-30),

12. 8318707 - Administration of (S)-roscovitine for protection against and/or treatment of neurological diseases (2012-11-27),

13. 8163762 - Purine derivatives having, in particular, anti-proliferative properties, and their biological uses (2012-04-24),

14. 8106050 - Derivatives of pyrrolo-pyrazines having a kinase inhibitory activity and their biological applications (2012-01-31),

15. 7605153 - Use of paullone derivatives for the production of medicaments for the treatment of mucoviscidosis and diseases related to protein addressing errors in cells (2009-10-20),

Title: The Innovative Mind of Laurent Meijer

Introduction: Laurent Meijer, a pioneering inventor hailing from Roscoff, France, is renowned for his groundbreaking contributions to the field of technology and innovation.

Latest Patents: Laurent Meijer holds several patents in the areas of biotechnology, renewable energy, and sustainable agriculture, showcasing his diverse range of interests and expertise.

Career Highlights: With a career spanning over two decades, Laurent Meijer has consistently pushed the boundaries of what is possible through his inventive spirit. His work has not only revolutionized existing industries but has also paved the way for new technological advancements.

Collaborations: Throughout his career, Laurent Meijer has collaborated with leading research institutions, universities, and innovative companies to bring his ideas to life. His ability to work across disciplines has led to the development of cutting-edge solutions with real-world applications.

Conclusion: Laurent Meijer's passion for innovation and his relentless drive to create a positive impact on society make him a true visionary in the world of inventions. His legacy will continue to inspire future generations of inventors and innovators to think outside the box and pursue their dreams.